Related Experiment Video
Updated: Jun 16, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Pulse pressure and progression of chronic kidney disease
Nishkanta Arulkumaran1, Ramaswamy Diwakar, Zaheer Tahir
1Renal and Transplantation Unit, St. George's Hospital NHS Trust, Tooting, London - UK.
Insights
Pulse pressure (PP) predicts adverse outcomes in chronic kidney disease (CKD). Higher baseline PP is linked to declining kidney function in mild to moderate CKD, suggesting it
Area of Science:
- Nephrology
- Cardiovascular Medicine
Background:
- Pulse pressure (PP) is a known predictor of adverse outcomes in patients undergoing hemodialysis and those with predialysis chronic kidney disease (CKD).
- The association between PP and kidney disease progression in mild to moderate CKD remains unclear.
Purpose of the Study:
- To investigate the relationship between pulse pressure (PP) and kidney disease progression in patients with mild to moderate CKD.
- To determine if PP is a better predictor of adverse renal outcomes than systolic blood pressure (SBP) or diastolic blood pressure (DBP) in this population.
Main Methods:
- A cohort of 329 CKD patients was followed for approximately 172 days.
- Baseline clinical characteristics, including estimated glomerular filtration rate (eGFR), SBP, DBP, and PP, were recorded.
- Changes in eGFR, SBP, DBP, and PP were monitored during the follow-up period.
Main Results:
- Declining kidney function (eGFR) was inversely related to baseline SBP and PP, but not DBP.
- Higher baseline PP was associated with a greater decline in eGFR during follow-up.
- Patients with declining eGFR had significantly higher baseline PP and SBP compared to those with stable eGFR.
Conclusions:
- Baseline pulse pressure (PP) emerged as the sole predictor of eGFR decline, independent of other clinical factors.
- A PP greater than 65 mm Hg was associated with declining renal function.
- PP is a more potent predictor of adverse renal outcomes in mild to moderate CKD than DBP or SBP.
Objectives:
Pulse pressure (PP) is a predictor of adverse outcomes in patients on haemodialysis and with predialysis chronic kidney disease (CKD). However, the relationship between PP and kidney disease progression is not clear in mild to moderate CKD, which this study aimed to investigate.
Methods:
CKD patients (n=329) were followed up for 172 +/- 93 days (mean +/- SD). The clinical characteristics at baseline were, age 64 +/- 17 years, 62% males, 27% diabetics, estimated glomerular filtration rate (eGFR) 39 +/- 18 ml/min per 1.73 m2, systolic blood pressure (SBP) 141 +/- 24 mm Hg, diastolic blood pressure (DBP) 76 +/- 12 mm Hg and PP 65 +/- 20 mm Hg. On follow-up, eGFR decreased (39 +/- 18 vs. 38+/-18 ml/min per 1.73 m2; p<0.01), SBP and PP improved (141 +/- 24 mm Hg vs. 133 +/- 19 mm Hg; p<0.001; and 65 +/- 20 mm Hg vs. 59+/-17 mm Hg; p<0.001), and DBP was unchanged.
Results:
Declining kidney function as assessed by eGFR was inversely related to baseline SBP (r=-0.15; p<0.01) and PP (r=-0.18; p<0.001), but no relationship with DBP was observed. During follow-up, baseline PP correlated with declining eGFR (r=-0.15; p<0.01) similar to SBP (r=-0.15; p<0.01), but DBP did not. Patients with declining eGFR had higher PP (69 +/- 20 mm Hg vs. 62 +/- 20 mm Hg; p<0.005), higher SBP (145 +/- 23 mm Hg vs. 138 +/- 25 mm Hg; p<0.05) but similar DBP (76 +/- 12 mm Hg vs. 76 +/- 12 mm Hg; p=0.8) compared with patients with stable eGFR.
Conclusions:
Baseline PP was the only predictor of eGFR decline adjusted for age, baseline eGFR, diabetes, haemoglobin and use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers. PP >65 mm Hg was associated declining renal function (log rank chi-square; p<0.05). This study suggests that PP is a better predictor of adverse renal outcome even in mild to moderate CKD, than DBP or even SBP.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Hypertension and Regulation of Blood Pressure
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
